Anonymous
Guest
Anonymous
Guest
Out with $34.9 M golden parachute. Don't cry for him
Out with $34.9 M golden parachute. Don't cry for him
High overhead and low sales? Run into the ground? Not accurate.
If Pyott can be criticized, despite the 2400% stock price increase since coming in as CEO, IT WOULD BE FOR NOT LEVERAGING HIS BALANCE SHEET WITH A GOOD GROWTH COMPANY ACQUISITION.
The Scottish are notoriously frugal and love to horde money....jus sayin.
He lied to us, never offered a stock program, gutted a great company and sold off to a Generic UK company, wtf? RIP AGN- alert cafe pharma. Allergan is dead!
rip pyott all you want but he has done exactly what he is supposed to do..maximize share holder value...cant argue with the results...now everyone grow up and understand this is business, not a charity organization
the other stuff at this point is nothing but a distraction to current actavis and allergan employees but again this is capitalism at work...
happy holidays